Metraipolis › archive › dc_442af02b32bf
Emerging causes of anticancer therapies-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: evidence from disproportionality analysis of the FDA… — Europe PMC PMID:40936888
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40936888
- DOI
- 10.3389/fimmu.2025.1646038
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T08:13:53.606Z
- SHA-256 of the archived text
30383d5fe3d2b3396b81fcf275af807b748bf2ae2dbe8dd0bac2dd04d6a39250- Stable URL of this page
https://metraipolis.com/documento/dc_442af02b32bf
How to cite
Emerging causes of anticancer therapies-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: evidence from disproportionality analysis of the FDA… — Europe PMC PMID:40936888 — Europe PMC (en), https://europepmc.org/article/MED/40936888 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_442af02b32bf (Metraipolis archive dc_442af02b32bf, sha256 30383d5fe3d2b3396b81fcf275af807b748bf2ae2dbe8dd0bac2dd04d6a39250)
BibTeX
@misc{dc442af02b32bf,
title = {Emerging causes of anticancer therapies-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: evidence from disproportionality analysis of the FDA… — Europe PMC PMID:40936888},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40936888},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_442af02b32bf; sha256 30383d5fe3d2b3396b81fcf275af807b748bf2ae2dbe8dd0bac2dd04d6a39250},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40936888. Agents can read the archived copy with the MCP tool read_document.